{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:41:43Z","timestamp":1790743303639,"version":"4.1.0"},"reference-count":49,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T00:00:00Z","timestamp":1318896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:p>Evenepoel P, Sprangers B, Lerut E, Bammens B, Claes K, Kuypers D, Meijers B, Vanrenterghem Y. Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study. \u2028Clin Transplant 2011 DOI: 10.1111\/j.1399\u20100012.2011.01524.x. \u2028\u00a9 2011 John Wiley &amp; Sons A\/S.<\/jats:p><jats:p><jats:bold>Abstract:\u2002<\/jats:bold><jats:bold> Background:\u2002<\/jats:bold> The calcimimetic cinacalcet is approved for treating secondary hyperparathyroidism in patients with chronic kidney disease on dialysis. Biochemical profiles and clinical outcomes in patients discontinuing cinacalcet at the time of transplantation are scarce.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> We performed a prospective observational cohort study, including 303 incident renal transplant recipients, of whom 21 were on cinacalcet treatment at the time of transplantation. Parameters of mineral metabolism and incidence of parathyroidectomy and nephrocalcinosis in patients discontinuing cinacalcet at the time of transplantation patients (\u201ccinacalcet +\u201d) were compared to cinacalcet\u2010na\u00efve patients (\u201ccinacalcet \u2013\u201d). Mean follow\u2010up was 35.6\u2003\u00b1\u200315.8\u2003months.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> At the time of transplantation, parameters of mineral metabolism were similar in both groups. Conversely, at month 3, serum ionized calcium (p\u2003=\u20030.0007), calcitriol (p\u2003=\u20030.02), biointact parathyroid hormone (p\u2003=\u20030.06) levels and urinary fractional excretion of phosphorus (p\u2003=\u20030.06) were higher, while serum phosphorus levels (p\u2003=\u20030.06) were lower in \u201ccinacalcet +.\u201d Analysis based on matching at the time of initiation showed that the course of post\u2010transplant mineral metabolism in cinacalcet\u2010treated patients (median treatment period 12.5\u2003months) vs. cinacalcet\u2010na\u00efve patients was identical. \u201cCinacalcet +\u201d patients are characterized by a high\u2010incidence proportion of both post\u2010transplant nephrocalcinosis (45% at month 3) and parathyroidectomy (28.6%). No difference in renal function was observed between \u201ccinacalcet +\u201d and \u201ccinacalcet\u2212\u201d patients.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Cinacalcet does not affect the course of secondary hyperparathyroidism in patients awaiting kidney transplantation. Biochemical profiles and a high parathyroidectomy rate suggest rebound hyperparathyroidism in renal transplant recipients discontinuing cinacalcet at the time of transplantation, which may be related to the short exposure time specific to this population. Risk\/benefit studies are urgently required to define the role of continued calcimimetic treatment in renal transplant recipients and to determine the optimal treatment of secondary hyperparathyroidism in patients listed for transplantation.<\/jats:p>","DOI":"10.1111\/j.1399-0012.2011.01524.x","type":"journal-article","created":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T10:08:06Z","timestamp":1319537286000},"page":"393-402","source":"Crossref","is-referenced-by-count":39,"title":["Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study"],"prefix":"10.1111","volume":"26","author":[{"given":"Pieter","family":"Evenepoel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Sprangers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Lerut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Bammens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Claes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Kuypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Vanrenterghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,10,18]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001754"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000034202.91413.EB"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V12102131"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000133041.27682.A2"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp144"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031633"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.09505.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00368.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00596.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/oxfordjournals.ndt.a027676","article-title":"Bone demineralization after renal transplantation: contribution of secondary hyperparathyroidism manifested by hypercalcaemia","volume":"11","author":"Setterberg L","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90484-4"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00938.x"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02792.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfp167"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2009.06.073"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm044"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-005-0625-4"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.04.029"},{"key":"e_1_2_7_20_2","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/clinchem\/30.11.1731","article-title":"Two direct (nonchromatographic) assays for 25\u2010hydroxyvitamin D","volume":"30","author":"Bouillon R","year":"1984","journal-title":"Clin Chem"},{"key":"e_1_2_7_21_2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/clinchem\/26.5.562","article-title":"A radioimmunoassay for 1,25\u2010dihydroxycholecalciferol","volume":"26","author":"Bouillon R","year":"1980","journal-title":"Clin Chem"},{"key":"e_1_2_7_22_2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/clinchem\/36.2.271","article-title":"Immunoradiometric assay of parathyrin with polyclonal and monoclonal region\u2010specific antibodies","volume":"36","author":"Bouillon R","year":"1990","journal-title":"Clin Chem"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001606"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00982.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03920808"},{"key":"e_1_2_7_26_2","first-page":"67","article-title":"Calcium metabolism and hyperparathyroidism after renal transplantation","volume":"52","author":"Cundy T","year":"1983","journal-title":"Q J Med"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2007.03.025"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01978.x"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027843"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197308232890804"},{"key":"e_1_2_7_31_2","first-page":"92","article-title":"Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland","volume":"8","author":"Parfitt AM","year":"1982","journal-title":"Miner Electrolyte Metab"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5484.1504"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh128"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn654"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl560"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06141108"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn717"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm177"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181728a2d"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1159\/000151722"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.12.065"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp115"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000141960.01035.28"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2007.00690.x"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm270"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00500705"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01475.x"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000253429.33198.2f"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000232452.80018.ad"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2007.07.079"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0012.2011.01524.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0012.2011.01524.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T13:39:55Z","timestamp":1698759595000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2011.01524.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,18]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1111\/j.1399-0012.2011.01524.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2011.01524.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,18]]}}}